Cargando…
Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial
BACKGROUND: The antidiabetic and hypoglycemic effects of chitosan have been reported in previous studies. We have previously shown that chitosan oligosaccharide reduces postprandial blood glucose levels in vivo. We conducted a short-term crossover study to support the results of the previous study....
Autores principales: | Jeong, Sarang, Min Cho, Jung, Kwon, Young-In, Kim, Seong-Chul, Yeob Shin, Dong, Ho Lee, Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828684/ https://www.ncbi.nlm.nih.gov/pubmed/31685797 http://dx.doi.org/10.1038/s41387-019-0099-4 |
Ejemplares similares
-
Molecular Weight Dependent Glucose Lowering Effect of Low Molecular Weight Chitosan Oligosaccharide (GO2KA1) on Postprandial Blood Glucose Level in SD Rats Model
por: Jo, Sung-Hoon, et al.
Publicado: (2013) -
Effect of mulberry leaf extract with enriched 1‐deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism
por: Asai, Akira, et al.
Publicado: (2011) -
Fasting plasma glucose levels and coronary artery calcification in subjects with impaired fasting glucose
por: Eun, Young-Mi, et al.
Publicado: (2016) -
Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes
por: Tönjes, Anke, et al.
Publicado: (2010) -
Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
por: Han, Eugene, et al.
Publicado: (2020)